← Leaderboards
Udayan Guha
Division Of Basic Sciences - Nci
$0
Attributed
$0
Total exposure
0
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding mix
By agency
—
By mechanism
—
Top collaborators
No co-investigators on record.
Most similar at Division Of Basic Sciences - Nci
Same institution · by research overlap
Others in their field
Top investigators on “Lung Adenocarcinoma”
- David Heimbrook · Leidos Biomedical Research, Inc.$39,462,948
- Charles A Coltman · Southwest Oncology Group$18,209,974
- Matthew L Meyerson · Brigham And Women'S Hospital$16,851,337
- Joan Massague · Sloan-Kettering Institute For Cancer Res$14,772,714
- Steven A Belinsky · Lovelace Biomedical &Environmental Res$14,359,070
- Larry J Shapiro · University Of California San Francisco$14,273,023
Research focus
Lung AdenocarcinomaMass Spectrum AnalysisMutationEpidermal Growth Factor ReceptorMalignant Neoplasm Of LungProteinsMutantSignal TransductionCell LineBasePhosphotransferasesSignal PathwayTyrosine PhosphorylationTyrosine Kinase InhibitorPhosphorylationLung TumorigenesisErlotinibSiteTumorCollaborationsResearch StudyTumor TissueProteomicsKras2 Gene
Grant awards (48)
Clinical Protocols in the Cancer Signaling Networks Section$554,270
ZIA · FY2020 · CA · contact PI
Protein phosphorylation downstream of mutant EGFR kinases$415,702
ZIA · FY2020 · CA · contact PI
Integrated proteogenomics to identify neopeptides presented by MHC Class I$277,134
ZIA · FY2020 · CA · contact PI
In-patient hospice and rapid autopsy to interrogate tumor heterogeneity$138,568
ZIA · FY2020 · CA · contact PI
Protein phosphorylation downstream of mutant EGFR kinases$764,528
ZIA · FY2019 · CA · contact PI
Clinical Protocols in the Cancer Signaling Networks Section$764,528
ZIA · FY2019 · CA · contact PI
In-patient hospice and rapid autopsy to interrogate tumor heterogeneity$382,264
ZIA · FY2019 · CA · contact PI
Protein phosphorylation downstream of mutant EGFR kinases$754,830
ZIA · FY2018 · CA · contact PI
Clinical Protocols in the Cancer Signaling Networks Section$526,625
ZIA · FY2018 · CA · contact PI
In-patient hospice and rapid autopsy to interrogate tumor heterogeneity$368,638
ZIA · FY2018 · CA · contact PI
Identification of potentially active tyrosine kinases in lung cancer$35,109
ZIA · FY2018 · CA · contact PI
Role of MIG6 in mutant EGFR-driven lung tumorigenesis$35,109
ZIA · FY2018 · CA · contact PI
Comparison of substrate specificities of wild type and mutant EGFR kinases$35,109
ZIA · FY2018 · CA · contact PI
Protein phosphorylation downstream of mutant EGFR kinases$838,579
ZIA · FY2017 · CA · contact PI
Clinical Protocols in the Cancer Signaling Networks Section$487,546
ZIA · FY2017 · CA · contact PI
In-patient hospice and rapid autopsy to interrogate tumor heterogeneity$390,036
ZIA · FY2017 · CA · contact PI
Identification of potentially active tyrosine kinases in lung cancer$97,509
ZIA · FY2017 · CA · contact PI
Role of MIG6 in mutant EGFR-driven lung tumorigenesis$97,509
ZIA · FY2017 · CA · contact PI
Comparison of substrate specificities of wild type and mutant EGFR kinases$39,004
ZIA · FY2017 · CA · contact PI
Protein phosphorylation downstream of mutant EGFR kinases$759,152
ZIA · FY2016 · CA · contact PI
Clinical Protocols in the Cancer Signaling Networks Section$399,554
ZIA · FY2016 · CA · contact PI
In-patient hospice and rapid autopsy to interrogate tumor heterogeneity$399,554
ZIA · FY2016 · CA · contact PI
Role of MIG6 in mutant EGFR-driven lung tumorigenesis$199,776
ZIA · FY2016 · CA · contact PI
Identification of potentially active tyrosine kinases in lung cancer$199,776
ZIA · FY2016 · CA · contact PI
Comparison of substrate specificities of wild type and mutant EGFR kinases$39,956
ZIA · FY2016 · CA · contact PI
Protein phosphorylation downstream of mutant EGFR kinases$810,863
ZIA · FY2015 · CA · contact PI
Identification of potentially active tyrosine kinases in lung cancer$405,432
ZIA · FY2015 · CA · contact PI
Role of MIG6 in mutant EGFR-driven lung tumorigenesis$210,825
ZIA · FY2015 · CA · contact PI
In-patient hospice and rapid autopsy to interrogate tumor heterogeneity$162,173
ZIA · FY2015 · CA · contact PI
Compare substrate specificities of wild type and mutant EGFR kinases.$32,435
ZIA · FY2015 · CA · contact PI
Role of MIG6 in mutant EGFR-driven lung tumorigenesis$469,802
ZIA · FY2014 · CA · contact PI
Protein phosphorylation downstream of mutant EGFR kinases$427,093
ZIA · FY2014 · CA · contact PI
Identification of potentially active tyrosine kinases in lung cancer$355,911
ZIA · FY2014 · CA · contact PI
In-patient hospice and rapid autopsy to interrogate tumor heterogeneity$142,364
ZIA · FY2014 · CA · contact PI
Compare substrate specificities of wild type and mutant EGFR kinases.$28,473
ZIA · FY2014 · CA · contact PI
Protein phosphorylation downstream of mutant EGFR kinases$382,591
ZIA · FY2013 · CA · contact PI
Role of ERRFI1 in mutant EGFR-driven lung tumorigenesis$382,591
ZIA · FY2013 · CA · contact PI
Identification of potentially active tyrosine kinases in lung cancer$318,825
ZIA · FY2013 · CA · contact PI
In-patient hospice and rapid autopsy to interrogate tumor heterogeneity$127,530
ZIA · FY2013 · CA · contact PI
Compare substrate specificities of wild type and mutant EGFR kinases.$63,766
ZIA · FY2013 · CA · contact PI
Protein phosphorylation downstream of mutant EGFR kinases$493,134
ZIA · FY2012 · CA · contact PI
Role of ERRFI1 in mutant EGFR-driven lung tumorigenesis$369,851
ZIA · FY2012 · CA · contact PI
Identification of potentially active tyrosine kinases in lung cancer$246,567
ZIA · FY2012 · CA · contact PI
Compare substrate specificities of wild type and mutant EGFR kinases.$123,284
ZIA · FY2012 · CA · contact PI
Protein phosphorylation downstream of mutant EGFR kinases$430,742
ZIA · FY2011 · CA · contact PI
Compare substrate specificities of wild type and mutant EGFR kinases.$239,301
ZIA · FY2011 · CA · contact PI
Identification of potentially active tyrosine kinases in lung cancer$191,441
ZIA · FY2011 · CA · contact PI
Role of ERRFI1 in mutant EGFR-driven lung tumorigenesis$95,720
ZIA · FY2011 · CA · contact PI